Using Generative Artificial Intelligence (AI) to Create Patient-Friendly Discharge Summaries

June 5, 2025 updated by: NYU Langone Health

Using Generative Artificial Intelligence to Transform Discharge Summaries Into Patient-Friendly Language and Format

This will be an open-label, parallel-group, randomized trial. Patients will be randomized to review the patient-friendly discharge instructions at the time of discharge (intervention group) vs the standard of care. The intervention differs from the standard of care in that patients will be given additional medical documentation in the intervention group.

Study Overview

Study Type

Interventional

Enrollment (Actual)

61

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • New York
      • New York, New York, United States, 10016
        • NYU Langone Health

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Admitted to Inpatient Medicine unit at NYULH
  • Able to read and understand English
  • Willing and able to consent to this research

Exclusion Criteria:

  • Inpatient Hospice
  • Discharged on home hospice

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Generative AI Discharge Instructions
At the time of discharge, patients will receive patient-friendly discharge instructions generated by GPT-4, an advanced natural language processing model, with the aim of enhancing patient readability and understandability in the discharge information.
Patient-friendly hospital discharge instructions generated by GPT-4, an advanced natural language processing model.
Active Comparator: Standard of Care Discharge Instructions
At the time of discharge, patients will receive standard discharge instructions (i.e., not generated by GPT-4).
Standard hospital discharge instructions.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of Summaries with Positive Outcome on Composite Measure of Readability and Understandability
Time Frame: Day 1 (At Discharge)

This is a composite outcome measure. Readability of discharge summaries will be measured using the Flesch-Kincaid Grade Level assessment, which measures how challenging a text may be for readers. Scores on the Flesch-Kincaid assessment are rated as follows:

0-3: Basic reading level, (kindergarten or elementary school) 3-6: Basic reading level, (elementary school ) 6-9: Average reading level, (middle school) 9-12: Average reading level, (high school) 11-18: Skilled readers.

Understandability will be evaluated by the presence of simplified description of primary diagnosis and hospital intervention.

Summaries with both 1) presence of simplified description of primary diagnosis and hospital intervention, and 2) a Flesch-Kincaid grade level greater than or equal to 6 and less than 8, will be considered to have a "positive outcome."

Day 1 (At Discharge)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes made to AI-Generated Content
Time Frame: Day 1 (At Discharge)
Changes made to content will be assessed using edit distance.
Day 1 (At Discharge)
AI-Generated Content Perception Survey: Safety
Time Frame: Day 1 (At Discharge)
Patients will be given a survey in which they are asked whether they feel safe with the discharge instructions they were provided. The total score is the number of participants who respond "Yes, definitely" or "Yes, somewhat" to the question.
Day 1 (At Discharge)
AI-Generated Content Perception Survey: Understandability
Time Frame: Day 1 (At Discharge)
Patients will be given a survey in which they are asked whether the instructions were easy to understand. The total score is the number of participants who respond "Yes, definitely" or "Yes, somewhat" to the question.
Day 1 (At Discharge)
AI-Generated Content Perception Survey: Empathy
Time Frame: Day 1 (At Discharge)
Patients will be given a survey in which they are asked whether the instructions were written in an empathetic manner. The total score is the number of participants who respond "Yes, definitely" or "Yes, somewhat" to the question.
Day 1 (At Discharge)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jonah Zaretsky, NYU Langone Health

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 29, 2025

Primary Completion (Actual)

May 22, 2025

Study Completion (Actual)

May 22, 2025

Study Registration Dates

First Submitted

November 27, 2024

First Submitted That Met QC Criteria

November 27, 2024

First Posted (Actual)

December 2, 2024

Study Record Updates

Last Update Posted (Actual)

June 6, 2025

Last Update Submitted That Met QC Criteria

June 5, 2025

Last Verified

June 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • 23-01544

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Data collected from usual clinical care; these data cannot be easily deidentified or shared.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hospital Discharge Summary Understanding

Clinical Trials on AI-Generated Discharge Instructions

Subscribe